diabetes and more
Follow
Find
35.5K views | +8 today
diabetes and more
Important news for those concerned with all types of diabetes, associated autoimmune diseases, & health
Your new post is loading...
Your new post is loading...
Scooped by Ellen H Ullman, MSW
Scoop.it!

ASHKELON, Israel: Integrity Applications Receives CE Mark Approval for Its GlucoTrack® Model DF-F Glucose Monitoring Device | Business Wire | Rock Hill Herald Online

Integrity Applications, Inc. (OTC/QB: IGAP) announced today that it has received CE Mark approval for its GlucoTrack® DF-F non-invasive blood glucose measurement device.
more...
No comment yet.
Rescooped by Ellen H Ullman, MSW from healthcare technology
Scoop.it!

A remote monitor embedded in insulin pen caps could help personalize diabetes treatment

A remote monitor embedded in insulin pen caps could help personalize diabetes treatment | diabetes and more | Scoop.it

A health IT startup has embedded a remote monitor in an insulin pen cap to track adherence and spot potential dosage problems early as part of Sanofi's Data Design Diabetes challenge.

 

The Sanofi US competition to encourage companies to devise new ways to improve outcomes and lower healthcare costs associated with diabetes has its demo day today. In a contest that generally revolves around various health IT approaches, one company has developed a remote monitoring device to generate big data using the cap of an insulin pen.

 

Cambridge, Massachusetts-based Common Sensing produced the GoCap — a replacement cap for pre-filled insulin pens that records the level of insulin administered daily and the times it was taken. It transmits that information using Bluetooth to a mobile phone or connected glucometer. The idea is to provide a steady stream of relevant information transmitted in an easily digestable format to alert healthcare professionals to potential problems early enough before they require hospitalization and ramp up healthcare costs.

 

James White co-founded Common Sensing with Richard Whalley, both MIT graduates. In a phone interview with MedCity News, White — who is also the chief technology officer — said one reason for starting the company is that the data to gauge risk in diabetes patients just isn’t there.

 

The device offers a way for physicians and patients to gain insight into daily insulin use over time not only to confirm whether the patient is taking their medicine, but also to help physicians adjust the prescribed amount if needed. For example, maybe the patient is not taking big enough dose of insulin in the morning but needs a smaller dose at night.

 


Via nrip
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Clinical Trials Discriminate Against Older Persons with Diabetes | GeriPal - Geriatrics and Palliative Care Blog

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

No Such Thing As Type 2 Diabetes? Why Old Notions Of 'Disease' Need Revamping

No Such Thing As Type 2 Diabetes? Why Old Notions Of 'Disease' Need Revamping | diabetes and more | Scoop.it
Diabetes is growing by leaps and bounds. But one researcher says, if we're going to solve the problem, we've got to overhaul our approach.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Rookie Will Pericak Overcoming Diabetes  

Rookie Will Pericak Overcoming Diabetes   | diabetes and more | Scoop.it
Diagnosed when he was 15, DE Will Pericak has to constantly monitor his body.  
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Predicting the Optimal Basal Insulin Infusion Pattern in Children and Adolescents on Insulin Pumps

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Johns Hopkins Scientist Slams Flu Vaccine

A Johns Hopkins scientist has issued a blistering report on influenza vaccines in the British Medical Journal (BMJ).
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Diabetes in California schools: State's high court to hear legal battle over insulin shots

Diabetes in California schools: State's high court to hear legal battle over insulin shots | diabetes and more | Scoop.it
California Supreme Court to review whether unlicensed school employees can give insulin to diabetic students; nurses say it would jeopardize student safety.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Patent row: Delhi HC to hear diabetes drug case

The patent battle between US pharmaceuticals major Merck Sharp and Dohme (MSD) and Indian firm Glenmark Pharmaceuticals over the sale of diabetes drug Januvia comes up for hearing in the Delhi High Court on Thursday.
more...
Mark Chataway's curator insight, May 25, 2013 11:33 AM

MSD had done the right thing here: the medicine in India cost about 20% of what it cost in Western markets. MSD had also licensed an Indian brand of the drug.  If thisthe Court tolerates this kind of treatment of comapnies which use responsible pricing, don't expect many others to try it

Scooped by Ellen H Ullman, MSW
Scoop.it!

Disney Channel, What they should know about how a kid with Celiac Disease grows up

Disney has gotten a lot of backlash from the Celiac community for standing up for what we believe in, standing up for what we think is right, and standing up for our kids sakes. If you haven’t heard...
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

GRADE Trial to Compare Top Type 2 Diabetes Drugs

Researchers are launching a large-scale comparative effectiveness trial that will help determine which of the top type 2 diabetes drugs are best for glycemic control.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Go Away With ... Gary Forbes

Go Away With ... Gary Forbes | diabetes and more | Scoop.it
Born in Colon, Panama, and raised in Brooklyn, N.Y., Gary Forbes had basketball on his mind when he was growing up. When he discovered he had Type 1 diabetes , he worried that it would derail his NBA plans.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

NIH begins recruitment for long-term study of diabetes drug efficacy

NIH is looking for volunteers to take part in a study to compare the long-term benefits and risks of four widely used type 2 diabetes drugs
Ellen H Ullman, MSW's insight:

Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study.

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

AACE Algorithm Offers New Guidance on Managing T2D How Does It Compare With ADA/EASD Guidelines Anne L. Peters, MD, CDE

Ellen H Ullman, MSW's insight:

Free login required

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Around the Diabetes Blogosphere: May 2013 Edition

We’re now at the end of the fifth month of 2013, which is simply amazing — how quickly this year is going by!
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Are current clinical trials in diabetes addressing important issues in diabetes care? - Springer

Are current clinical trials in diabetes addressing important issues in diabetes care? - Springer | diabetes and more | Scoop.it
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

George S. Eisenbarth: Insulin and Type 1 Diabetes

Ellen H Ullman, MSW's insight:

George S. Eisenbarth, MD, PhD, could be considered a natural conduit in the research of type 1 diabetes (T1D) and the fields of endocrinology and immunology. His recognition of T1D as a chronic autoimmune disease has advanced the field toward prediction, prevention, and clinical trials. His focus on insulin as the key autoantigen in islet autoimmunity unraveled the molecular basis of the insulin autoimmune response, leading to experimental antigen-specific therapies that are presently approaching clinical translation and represent a model approach for the treatment of human T1D and other autoimmune diseases.

more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Incretins and Type 1 Diabetes? (S2-16 )

In this episode of the Edelman Report, Dr. Edelman discusses Incretins and Type 1's?
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

EEOC Issues Updated Publications on Specific Disabilities - Employment and HR - United States

EEOC Issues Updated Publications on Specific Disabilities - Employment and HR - United States | diabetes and more | Scoop.it
25 May 2013 - United States - Employment and HR - EEOC Issues Updated Publications on Specific Disabilities - Day Pitney LLP - The EEOC recently issued four revised documents in its disability discrimination Questions and Answers Series, addressing...
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

EMA Biosimilars Draft: Non-EU Reference Avoids Clinical Trial Repeats

EMA Biosimilars Draft: Non-EU Reference Avoids Clinical Trial Repeats | diabetes and more | Scoop.it
The EMA (European Medicines Agency) has released draft guidelines on biosimilars allowing non-EEA comparators to be used in limited circumstances.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Florida Bill Blocks Biosimilar Limitations

Florida Bill Blocks Biosimilar Limitations | diabetes and more | Scoop.it
A bill passed by the Florida legislature would allow pharmacists to substitute biosimilars for brand-name biologics provided that a number of criteria are met.
more...
No comment yet.
Scooped by Ellen H Ullman, MSW
Scoop.it!

Echo Therapeutics Announces Successful Unveiling of Symphony® CGM System

Echo Therapeutics Announces Successful Unveiling of Symphony® CGM System | diabetes and more | Scoop.it
PHILADELPHIA, May 23, 2013 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its...
more...